
The Senior Quality Training Specialist is responsible for the development, administration, delivery, and continuous improvement of the Quality Training program within the Quality Management System (QMS). This role independently develops and facilitates training for employees across the organization and partners with Quality, functional subject matter experts, and business stakeholders to ensure employees have the knowledge and skills necessary to perform their responsibilities in accordance with applicable procedures, regulatory requirements, and Company standards.
The Senior Specialist serves as a key subject matter resource for Quality training processes with responsibility for training delivery, curriculum management, compliance monitoring, training effectiveness, and continuous improvement. This role requires a strong facilitator who can translate complex Quality and compliance concepts into clear, engaging, and practical learning experiences.
This position is hybrid-based requiring 2-3 days onsite in our Waltham, MA Headquarters.
Responsibilities:
Qualifications:

Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor) as well as early-stage pipeline candidates. The company is developing RDX10531, a next-generation NHE3 inhibitor with potential application across multiple therapeutic areas. Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada.
Community Guidelines: https://rb.gy/07ltg3